Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 29

Sort by

Sort Order Select

Journal Articles

Combination of CD19 and CD70 Specific Chimeric Antigen Receptor T Cells Achieves Long-Term Disease-Free Survival in Relapsed and Refractory Primary Central Nervous System Diffuse Large B Cell Lymphoma

Sanfang Tu, MD PhD, Rui Huang, MD PhD, Xuan Zhou, MD, Yanjie He, MD PhD, Zhao Liang, MD PhD, Lei Wang, MD PhD, Lung-Ji Chang, PhD, Yuhua Li, MD PhD

Blood (2018) 132 (Supplement 1): 5389.

https://doi.org/10.1182/blood-2018-99-117694

Published: 2018

Journal Articles

Central Nervous System Complications after Allogeneic Hematopoietic Stem Cell Transplantation: The Role of Calcineurin Inhibitors

Elisa Sala, MD, Stephanie von Harsdorf, MD, Verena Wais, MD, Thanh Mai Anne Nguyen, MD, Raphael Beck, MD, Hartmut Döhner, MD, Donald Bunjes, MD, Florian Kuchenbauer, MD PhD

Blood (2018) 132 (Supplement 1): 4601.

https://doi.org/10.1182/blood-2018-99-114977

Published: 2018

Journal Articles

Lost to Follow-up Rates Are Higher in Pediatric Than Adult Survivors, but Not By Transplant Type: A Report from the Center for International Blood and Marrow Transplant Research

David K. Buchbinder, MD MSHS, Ruta Brazauskas, PhD, Khalid Bo-Subait, Karen K. Ballen, MD, Theresa E. Hahn, PhD, Tami D John, MD, Susan K Parsons, MD MRP, Shahrukh K. Hashmi, MD MPH, Nandita Khera, MD, William A. Wood, MD MPH, Wael Saber, MD MS

Blood (2018) 132 (Supplement 1): 2260.

https://doi.org/10.1182/blood-2018-99-116531

Published: 2018

Journal Articles

Safety and Feasibility of Outpatient Autologous Hematopoietic Stem Cell Transplantation in Pediatric Patients with Central Nervous System Tumors

Jane Y Koo, MD, Jean Mulcahy-Levy, MD, Nicholas K Foreman, MD, Amy K Keating, MD, Brandon Nuechterlein, P.A., Stacy Silverman, R.N.

Blood (2018) 132 (Supplement 1): 2159.

https://doi.org/10.1182/blood-2018-99-109711

Published: 2018

Journal Articles

A New Prognostic Scoring System to Predict Disease Progression and Mortality in Patients with Newly Diagnosed Primary CNS Lymphoma

Chia-Jen Liu, MD PhD, Chia-Hsin Lin, MD, Ying-Chung Hong, MD, Ching-Fen Yang, MD, Huai-Che Yang, MD, Li-Yu Fay, MD, Chiu-Mei Yeh, MS, Jyh-Pyng Gau, MD, Yuan-Bin Yu, MD, Tzeon-Jye Chiou, MD, Jin-Hwang Liu, MD PhD, Yao-Chung Liu, MD, Chung-Jen Teng, MD

Blood (2017) 130 (Supplement 1): 2858.

https://doi.org/10.1182/blood.V130.Suppl_1.2858.2858

Published: 2017

Journal Articles

Primary Central Nervous System Lymphoma and the Blood-Brain Barrier

Nancy D. Doolittle, PhD, Rochelle Fu, PhD, Prakash Ambady, MD, Edward A Neuwelt, MD

Blood (2016) 128 (22): 928.

https://doi.org/10.1182/blood.V128.22.928.928

Published: 2016

Journal Articles

Elevation of Plasma α-Synuclein Levels Is Diagnostic of Malignant or Invasive Central Nervous System Neoplasms

Catherine M Stefaniuk, DO, Quinn Ostrom, MA MPH, Jill Barnholtz-Sloan, PhD, Joseph Willis, MD, Robert W. Maitta, MDPhD

Blood (2015) 126 (23): 5597.

https://doi.org/10.1182/blood.V126.23.5597.5597

Published: 2015

Journal Articles

Refractory Extranodal Nasal NK/T-Cell Lymphoma with CNS Involvement Treated with Radiotherapy and Pralatrexate: Case Report

Rico Enrique, Hematologist

Blood (2015) 126 (23): 5060.

https://doi.org/10.1182/blood.V126.23.5060.5060

Published: 2015

Journal Articles

Pediatric Leukemia/Lymphoma Patients Have Worse Patient-Reported Health Status Than Pediatric Solid Tumor and CNS Tumor Patients during Intensive Treatment

Sarah K. Dobrozsi, MD MS, Ke Yan, PhD, Raymond G. Hoffmann, PhD, Julie A. Panepinto, MD MSPH

Blood (2015) 126 (23): 4489.

https://doi.org/10.1182/blood.V126.23.4489.4489

Published: 2015

Journal Articles

Increased Risk of Venous Thromboembolism in Primary Central Nervous System Lymphoma Patients Undergoing Therapy

Gayathri Ravi, MD, Brenda Cooper, MD, Erica L Campagnaro, MD, Basem M. William, MD, Richard J. Creger, Pharm D, Stanton L. Gerson, Marcos De Lima, MD, Hillard M. Lazarus, MD, Paolo Caimi, MD

Blood (2014) 124 (21): 5431.

https://doi.org/10.1182/blood.V124.21.5431.5431

Published: 2014

Journal Articles

Young Paternal Age and Risk Of Infant Acute Lymphoblastic Leukemia

Julie A Ross, PhD, Todd E Druley, MD, PhD, Kimberly J Johnson, Rachel K. Fonstad, M.S., Julie von Behren, MPH, Beth Mueller, PhD, Susan Carozza, PhD, Eric J. Chow, MD, MPH, Colleen McLaughlin, PhD, Peggy Reynolds, PhD, Erin Fox, PhD, Scott Horel, Logan G. Spector, PhD

Blood (2013) 122 (21): 1395.

https://doi.org/10.1182/blood.V122.21.1395.1395

Published: 2013

Journal Articles

A Pilot Study to Assess Alterations in Trace Element Status in Pediatric Patients with Malignancies.

Jong Chung, MD, Ellen B Fung, PhD, RD, CCD, James H. Feusner, M.D.

Blood (2012) 120 (21): 3183.

https://doi.org/10.1182/blood.V120.21.3183.3183

Published: 2012

Journal Articles

A Randomised Dose De-Escalation Safety Study of Oral Fludarabine, ±Oral Cyclophosphamide and Intravenous Rituximab (OFOCIR) As First-Line Therapy of Fit Patients with Chronic Lymphocytic Leukaemia (CLL) Aged ≥65 Years – End of Recruitment Analysis of Response and Toxicity of the Australasian Leukaemia and Lymphoma Group (ALLG) and CLL Australian Research Consortium (CLLARC) CLL5 Study

Stephen P Mulligan, MBBS, PhD, FRACP, FRCPA, Devinder S Gill, MB ChB, MRCP (UK), FRCPath (Lond), Paul Turner, MBBS FRACP FRCPA, William E. P. Renwick, MBBS, FRACP, FRCPA, Rosemary Harrup, MB BS, FRACP, FRCPA, Maya Latimer, MBBS, FRACP, FRCPA, Naomi Mackinlay, MB BS, FRACP, FRCPA, Leanne Berkahn, MB ChB, FRACP, FRCPA, David Simpson, FRACP, FRCPA, MBChB, Philip Campbell, MBBS, FRACP, FRCPA, Campbell Tiley, MBBS, FRACP, FRCPA, Gavin Cull, MBBS, DM, FRACP, FRCPA, Marnie Collins, BCom, BSc(Hons), Paul Cortissos, Melanie Sulda, B.Sc, Ph.D., Giles Best, B.Sc., Ph.D., Bryone J Kuss, MBBS, PhD, FRCPA, FRACP

Blood (2012) 120 (21): 436.

https://doi.org/10.1182/blood.V120.21.436.436

Published: 2012

Journal Articles

Second Neoplasms After Treatment of Childhood Acute Lymphoblastic Leukemia

Blood (2012) 120 (21): 661.

https://doi.org/10.1182/blood.V120.21.661.661

Published: 2012

Journal Articles

A Survey of Transfusion Practices in Pediatric Stem Cell Transplant Patients,

Rachel S. Bercovitz, M.D., Ralph R. Quinones, M.D.

Blood (2011) 118 (21): 3370.

https://doi.org/10.1182/blood.V118.21.3370.3370

Published: 2011

Journal Articles

Late Mortality After Hematopoietic Stem-Cell Transplantation for a Childhood Malignancy

Tal Schechter, MD, Jason Pole, PhD, Denise Darmawikarta, Bsc, Adam Gassas, MD, Mark L. Greenberg, MD, Muhammad Ali, MD, John J Doyle, MD, Paul Nathan, MD, FRCPC

Blood (2011) 118 (21): 4458.

https://doi.org/10.1182/blood.V118.21.4458.4458

Published: 2011

Journal Articles

Safety and Efficacy of Hematopoietic Stem Cell Remobilization with Plerixafor (Mozobil ® ) + G-CSF In Pediatric Patients with Malignant Disorders

Shalini Shenoy, MD, Barbara Asselin, Jignesh Dalal, Rakesh Goyal, Jonathan L. Kaufman, MD, David Loeb, John McCarty, Kent Robertson, Caron Strahlendorf, Mark C. Walters, MD, Jennifer Angell, Dirk Huebner, MD, Peter J. Shaw, MA, MB, BS, MRCP, FRACP

Blood (2010) 116 (21): 2245.

https://doi.org/10.1182/blood.V116.21.2245.2245

Published: 2010

Journal Articles

Systemic Relapses In Primary CNS Lymphoma (PCNSL) - Unexpected Clonal Diversity

Lars Fischer, Michael Hummel, Prof., Agnieszka Korfel, Dido Lenze, Kristoph Jahnke, Philipp Kiewe, Michael Weller, Prof., Eckhard Thiel, Prof.

Blood (2010) 116 (21): 3125.

https://doi.org/10.1182/blood.V116.21.3125.3125

Published: 2010

Journal Articles

Clonally Related B-NHL Populations and Cell Lines Harbor Subsets with Significant Phenotypic and Functional Heterogeneity.

Sherry A. Wuensch, Randall M. Rossi, Richard Burack, Paul G. Rothberg, Craig T. Jordan, Faith M Young

Blood (2009) 114 (22): 1699.

https://doi.org/10.1182/blood.V114.22.1699.1699

Published: 2009

Journal Articles

Risk Factors for Candidemia in Pediatric Oncology Patients.

Theoklis E Zaoutis, MD, MSCE, Priya A Prasad, MPH, A. Russell Localio, JD, PhD, Anne Reilly, MD, Louis M Bell, MD, Thomas J Walsh, MD, Robert Gross, MD

Blood (2009) 114 (22): 4735.

https://doi.org/10.1182/blood.V114.22.4735.4735

Published: 2009

NARROW

Combination of CD19 and CD70 Specific Chimeric Antigen Receptor T Cells Achieves Long-Term Disease-Free Survival in Relapsed and Refractory Primary Central Nervous System Diffuse Large B Cell Lymphoma

Central Nervous System Complications after Allogeneic Hematopoietic Stem Cell Transplantation: The Role of Calcineurin Inhibitors

Lost to Follow-up Rates Are Higher in Pediatric Than Adult Survivors, but Not By Transplant Type: A Report from the Center for International Blood and Marrow Transplant Research

Safety and Feasibility of Outpatient Autologous Hematopoietic Stem Cell Transplantation in Pediatric Patients with Central Nervous System Tumors

A New Prognostic Scoring System to Predict Disease Progression and Mortality in Patients with Newly Diagnosed Primary CNS Lymphoma

Primary Central Nervous System Lymphoma and the Blood-Brain Barrier

Elevation of Plasma α-Synuclein Levels Is Diagnostic of Malignant or Invasive Central Nervous System Neoplasms

Refractory Extranodal Nasal NK/T-Cell Lymphoma with CNS Involvement Treated with Radiotherapy and Pralatrexate: Case Report

Pediatric Leukemia/Lymphoma Patients Have Worse Patient-Reported Health Status Than Pediatric Solid Tumor and CNS Tumor Patients during Intensive Treatment

Increased Risk of Venous Thromboembolism in Primary Central Nervous System Lymphoma Patients Undergoing Therapy

Young Paternal Age and Risk Of Infant Acute Lymphoblastic Leukemia

A Pilot Study to Assess Alterations in Trace Element Status in Pediatric Patients with Malignancies.

Second Neoplasms After Treatment of Childhood Acute Lymphoblastic Leukemia

A Survey of Transfusion Practices in Pediatric Stem Cell Transplant Patients,

Late Mortality After Hematopoietic Stem-Cell Transplantation for a Childhood Malignancy

Safety and Efficacy of Hematopoietic Stem Cell Remobilization with Plerixafor (Mozobil ® ) + G-CSF In Pediatric Patients with Malignant Disorders

Systemic Relapses In Primary CNS Lymphoma (PCNSL) - Unexpected Clonal Diversity

Clonally Related B-NHL Populations and Cell Lines Harbor Subsets with Significant Phenotypic and Functional Heterogeneity.

Risk Factors for Candidemia in Pediatric Oncology Patients.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only